Introduction Semaglutide Has rapidly gained recognition as a transformative medication in the treatment of type 2 diabetes and obesity. Initially developed for diabetes management, Semaglutide belongs to a class of drugs known as GLP-1 receptor agonists. These medications mimic the actions of a naturally occurring hormone in the body, glucagon-like https://online-cancer-consultatio73726.blog5.net/74272253/semaglutide-a-breakthrough-in-managing-diabetes-obesity-and-cardiovascular-health